Westover Capital Advisors, LLC Medtronic PLC Transaction History

Westover Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$87.4 - $113.09 $203,030 - $262,708	-2,323 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$100.58 - $112.38 $72,920 - $81,475	-725 Reduced 23.79%	2,323 $258,000
Q4 2021 Feb 14, 2022	SELL	$99.53 - $127.75 $43,196 - $55,443	-434 Reduced 12.46%	3,048 $315,000
Q2 2021 Aug 10, 2021	SELL	$118.19 - $131.5 $16,901 - $18,804	-143 Reduced 3.94%	3,482 $432,000
Q1 2021 May 18, 2021	SELL	$111.18 - $119.74 $8,783 - $9,459	-79 Reduced 2.13%	3,625 $428,000
Q4 2020 Feb 16, 2021	BUY	$100.57 - $117.14 $24,941 - $29,050	248 Added 7.18%	3,704 $434,000
Q3 2020 Nov 19, 2020	BUY	$90.13 - $108.78 $70,932 - $85,609	787 Added 29.49%	3,456 $359,000
Q2 2020 Aug 14, 2020	BUY	$84.11 - $103.33 $224,489 - $275,787	2,669 New	2,669 $245,000

2,288

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Westover Capital Advisors, LLC with notifications on news.